Natco Pharma shares surged 5% to Rs 1,569 after filing an ANDA with the US FDA for a generic cancer drug. The company aims for 180 days of marketing exclusivity.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Natco Pharma shares surged 5% to Rs 1,569 after filing an ANDA with the US FDA for a generic cancer drug. The company aims for 180 days of marketing exclusivity.
| Subscribe To Our Free Newsletter |
